Session Details
[29P]Drug delivery system in therapy/Genetic drug delivery system/Formulation and manufacturing of drugs (Solid · Semi-solid · Liquid dosage form)
Sat. Mar 29, 2025 8:30 AM - 3:00 PM JST
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Sat. Mar 29, 2025 11:30 PM - 6:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[29PA-268S]Optimization of azide loading to immune cell-derived extracellular vesicles via the mechanism of sialic acid metabolism
○Shunsuke Miyai1, Yuki Terada1, Daiki Tajimi1, Yuki Kobayashi1, Yu Ishima1 (1. Kyoto Pharm. Univ.)
[29PA-269]Effect of PEGylation for mRNA lipoplexes on protein expression and antibody production following administration of mRNA lipoplexes prepared using a modified ethanol injection method
○Yoshiyuki Hattori1, Min Tang1, Kumi Kawano1 (1. Mol. Pharm., Hoshi Univ.)
[29PA-270S]Evaluation of in vitro transfection with siRNA lipoplexes prepared using a modified ethanol injection method
○Aya Kurihara1, Mizuki Shinkawa1, Ayana Hattori1, Hanaka Suzuki1, Sora Endo1, Ayumu Ishii1, Yoshiyuki Hattori1 (1. Mol Pharm, Hoshi Univ)
[29PA-271S]Effect of PEGylation of siRNA lipoplexes prepared using a modified ethanol injection method on proliferation inhibitory effect against tumor cells
○Mizuki Shinnkawa1, Aya Kurihara1, Ryohei Shimizu1, Yoshiyuki Hattori1 (1. Mol Pharm, Hoshi Univ)
[29PA-272]Effect of the preparation methods on protein expression by cationic triacyl lipid-based mRNA lipoplexes
○Ryohei Shimizu1, Yoshiyuki Hattori1 (1. Mol. Pharm., Hoshi Univ.)
[29PB-273S]Usefulness of IL-12 mRNA-loaded lipid nanoparticles in treatment for glioblastoma
○Masami Watanabe1, Daiki Omata1, Lisa Munakata1, Yasuo Yoshioka2,3,4,5,6,7,8, Ryo Suzuki1 (1. Fac. Pharm.Sci. Teikyo Univ., 2. RIMD, Osaka Univ., 3. BIKEN, 4. Grad. Sch. Pharm. Sci., Osaka Univ., 5. CiDER,Osaka Univ., 6. OTRI,Osaka Univ., 7. CAMaD,Osaka Univ., 8. MEI,Osaka Univ.)
[29PA-274S]Development of Cellulose Nanocrystalline-Based Gene Delivery
○GAO YUAN1, Koki Ogawa1, Tetsuya Ozeki1 (1. Grad. Sch. Pharm. Sci., Nagoya City Univ)
[29PA-275S]Development of core-shell nanocarriers to promote the cytoplasmic release of encapsulated genes
○Reno Kinoshita1, Konatsu Ibe1, Nagisa Muto1, Yuichi Yamasaki1,2, Susumu Hama1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Ins. Pharm. Sci., Musashino Univ.)
[29PA-276S]Analysis of structural changes by surface charge regulation in γ-polyglutamic acid/polyethyleneimine/plasmid DNA ternary complexes
○Moe Nakashima1, Shintaro Fumoto1, Eriko Mabuchi1, Tomoaki Kurosaki1, Hirotaka Miyamoto1, Hitoshi Sasaki2, Koyo Nishida1 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ., 2. Institute of Tropical Medicine, Nagasaki Univ.)
[29PB-277]Development of polycatenane-based intracellular delivery carrier for biopharmaceuticals
○Taishi Higashi1, Toru Taharabaru1, Keiichi Motoyama1 (1. Grad. Sch. Pharm. Sci., Kumamoto Univ.)
[29PA-278S]The development of lipid nanoparticles to deliver antisense oligonucleotides targeting an intron retention-associated variant
○Katsunori Saito1, Akihide Yoshimi2, Tomohiro Asai1 (1. Grad. Sch. Parm. Sci., Univ. of Shizuoka., 2. National Cancer Center Japan)
[29PB-279S]Development of novel lipid nanoparticles to overcome the PEG dilemma and their application to cancer therapy
○Koki Yanagida1,2, Motoaki Kobayashi1,2, Wanphiwat Chintrakulchai1,2, Fumito Takada3, Koichi Ogi3, Junya Michinishi3, Tomoyuki Ohtake3, Kyohei Muguruma1,2, Yuto Honda1,2,4, Hiroyasu Takemoto5, Yutaka Miura1,2, Nobuhiro Nishiyama1,2,4 (1. Dept. of Life Sci. and Tech., Science Tokyo, 2. Lab. for Chem. and Life Sci., Science Tokyo, 3. NOF, 4. iCONM, 5. Grad. Sch. Med. Sci., Kyoto Prefecture Univ. of Medicine)
[29PA-280S]Systematic evaluation of intracellular behavior of lipid nanoparticles in human/mouse cancer cells
○Koki Ono1, Yuta Tamemoto1, Zhang Chongjie1, Yutaro Chino1, Rina Tanaka1, Liu Yi1, Katsuyuki Chida1, Yusuke Sato2, Hiroto Hatakeyama1 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Pharm. Sci., Hokkaido Univ.)
[29PB-281S]Site-specific delivery system to the brain tissue by a combination of ultrasound-responsive nanobubbles and low-frequency focused ultrasound
○Seiyo Numazawa1, Taiki Yamaguchi1, Yoko Endo-Takahashi1, Yoichi Negishi1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)
[29PA-282S]Exploration of optimal lipid nanoparticles for neutrophil-based mRNA delivery
○Nodoka Yahagi1, Ryohei Urata1, Tomoya Hikita1, Tomohiro Asai1 (1. University of Shizuoka)
[29PB-283]Dipeptide lipid-based lipid nanoparticles for mRNA cancer vaccine
○Takumi Sato1, Ruho Yamaguchi1, Sayaka Takahashi1, Katsuki Matayoshi1, Tomoya Hikita1, Nahoko Ozaki2, Kurata Makiko2, Tomohiro Asai1 (1. Pharm. Sci., Univ. of Shizuoka, 2. Sogo Pharrmaceutical Co., Ltd.)
[29PA-284S]Development of biodegradable micelle systems for mRNA delivery aimed at cancer therapeutics
○Satoru Yazaki1, Hazekawa Mai1, Daisuke Watase1, Ayano Yamada1, Mitsuhisa Koga1 (1. Fac. Pharm., Fukuoka Univ)
[29PB-285]Designing oral jelly formulation based on konjac glucomannan
○Tetsuya Shimoyama1, Honatsu Hattori1, Akari Yasuda1, Kunihiko Itoh1, Michiya Kobayashi1 (1. Sch. Pharm. Sci., Health Sci. Univ. of Hokkaido)
[29PA-286S]Design of lanthanum carbonate jelly formulation using starch/gellan gum mixture
○Honami Nakano1, Haruka Watanabe1, Hatsune Ikeda1, Tetsuya Shimoyama1, Kunihiko Itoh1, Michiya Kobayashi1 (1. Sch. Pharm. Sci., Health Sci. Univ. of Hokkaido)
[29PB-287]Design of oral liquid formulation using xyloglucan/locust bean gum mixture system
○Kunihiko Itoh1, Kazuha Ishida1, Tetsuya Shimoyama1, Michiya Kobayashi1 (1. Sch. Pharm. Sci., Health Sci. Univ. of Hokkaido)
[29PA-288S]Formulation design of novel sugar alcohol granules as excipients for orally disintegrating tablets
○Moemi Nakano1, Keita Kondo1, Toshiyuki Niwa1 (1. Meijo Univ.)
[29PB-289S]Development of convenient enteral nutritional tablet - Research on preparation approach -
○Mizuki Sato1, Keita Kondo1, Toshiyuki Niwa1 (1. Meijo Univ.)
[29PA-290S]Development of an annealing technique for dry-coated tablets using microwaving
○Katsunori Otake1, Keita Kondo1, Toshiyuki Niwa1 (1. Faculty of Pharmacy, Meijo University)
[29PB-291S]Influence of surfactants in transdermal absorbent gels
○Shino Inoue1, Kaana Ando2, Ikumi Sugiyama1, Yasuyuki Sadzuka1 (1. Sch. Pharm., Iwate Med. Univ. , 2. Grad. Sch. Pharm., Iwate Med. Univ.)
[29PA-292]Development of LNP manufacturing process using impingement jet mixer system
○Haruyuki Takahashi1, Ami Inoue1, Priyanka SawantHattori1, Yutaka Nishimoto1, Tomomi Sato1 (1. Takeda Pharmaceutical Company)
[29PB-293]Scale-up study of LNP drug product for investigational drug manufacturing
○Ryo Hidaka1, Yutaka Nishimoto1, Haruyuki Takahashi1, Ami Inoue1, Tomomi Sato1 (1. Takeda Pharmaceutical Company)
[29PA-294]Process development of buffer exchange for LNP manufacturing
○Ami Inoue1, Haruyuki Takahashi1, Yutaka Nishimoto1, Tomoya Takenaka1, Ryo Hidaka1, Tomomi Sato1 (1. Takeda Pharmaceutical Company)
[29PB-295]Formulation for thermostable Influenza HA Vaccine
○Nagisa Nakata1, Asumi Kanda1, Ryotarou Mitsumata1 (1. Denka Co., Ltd.)
[29PA-296S]Manufacturing of mini-tablets by direct compression using granulated lactose with different characteristics
○Fuzuki Kurita1, Ayumi Sakurada1, Shohei Nakamura1, Takatoshi Sakamoto1 (1. Coll. Pharm. Sci., Matsuyama Univ.)
[29PB-297]Effect of cellulose nanofiber with different particle sizes on the physical properties of mini-tablets manufactured via direct compression
○Shohei Nakamura1, Momoka Hamaoka1, Ayumi Sakurada1, Takatoshi Sakamoto1 (1. Coll. Pharm. Sci., Matsuyama Univ.)
[29PA-298S]Solubilized position of progesterone in gemini-type surfactant micelles
○Mai Tateno1, Kazutaka Koga1, Hiromichi Nakahara1 (1. Daiichi Univ. Pharm.)
[29PB-299S]Rapid freeze-drying of liposome formulations by microwave irradiation
○MAI NAKATA1, Yo Kamikawa2, Shuntaro Tsubaki3, Takayuki Furuishi4, Motoki Inoue1, Takefumi Yamashita1, Etsuo Yonemochi5 (1. Hoshi Univ.,, 2. Grad. Sch. Bioresour. Bioenviron. Sci., Kyushu Univ., 3. Fac. Agric., Kyushu Univ., 4. Fac. Pharm., Juntendo Univ., 5. Narita Sch. Pharm., IUHW.)
[29PA-300S]Preparation of Particles Containing Drugs Based on Formulation of Cyclodextrin-Metal Organic Framework Using Amorphous-Crystal Phase Transition
○Miki Nagatani1, Ryuta Togashi2, Peiwen Mo1, Yuzuki Nakayama1, Ryoma Tanaka1, Hiromasa Uchiyama1, Shunsuke Tanaka2, Kazunori Kadota1,3, Yuichi Tozuka1 (1. Osaka Med. Pharm. Univ., 2. Kansai Univ., 3. Wakayama Med. Univ.)
[29PB-301S]Investigation of dissolving microneedles containing amorphous salts with controlled drug dissolution.
○Tatsuyuki Aoyagi1, Hiromasa Uchiyama1, Daiki Morishita1, Ryoma Tanaka1, Kazunori Kadota2, Daisuke Ando3, Tatsuo Koide3, Yuichi Tozuka1 (1. Osaka Med. Pharm. Univ., 2. Wakayama Med. Univ., 3. National Institute of Health Sciences)
[29PA-302S]Influence of the addition of drugs on the structure and morphology of Supraparticles
○Ayaka Shimozono1, Yuzuki Nakayama1, Tero Kämäräinen1, Ryoma Tanaka1, Hiromasa Uchiyama1, Kazunori Kadota1,2, Yuichi Tozuka1 (1. Osaka Med. Pharm. Univ., 2. Wakayama Med. Univ.)
[29PB-303S]3D Printed Hydrogel Scaffold Loaded with Silver Nanoparticles for Localized Photothermal Therapy in Melanoma
○JAYITA DAS1, KOKI OGAWA1, TETSUYA OZEKI1 (1. Grad. Sch. Pharm Sci., Nagoya City Univ.)
[29PA-304S]Evaluation of Formation Mechanism of Dry Spherical Particles Using Synchrotron X-ray CT Imaging
○Michiru Koyama1, Yuito Nishiguchi1, Masataka Ito1, Hironori Suzuki1, Shuuji Noguchi1 (1. Toho University. Faculty of Pharmaceutical Sciences)
[29PB-305]Continuous monitoring of the hydration behavior of hydrophilic matrix tablets using time-domain NMR
○Yoshinori Onuki1, Hiromu Taguchi2, Shungo Kumada3, Kotaro Okada2 (1. Juntendo University, 2. University of Toyama, 3. Nichi-Iko Pharmaceutical Co., Ltd.)
[29PA-306]Formulation design of orally disintegrating films containing glibenclamide using a molecular complex composed of amino acids
○Takayuki Furuishi1,2, Sae Kamura2, Toranosuke Mimura2, Motoki Inoue2, Takefumi Yamashita2 (1. Juntendo Univ. Fac. Pharm., 2. Hoshi Univ.)
[29PB-307S]Design of catechin-containing jelly formulation with cyclodextrin addition to improve astringency and pH-dependent degradability
○Peiwen Mo1, Yuta Hatanaka1, Ryoma Tanaka1, Hiromasa Uchiyama1, Katsuhiko Minoura1, Kazunori Kadota2, Yuichi Tozuka1 (1. Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 2. Faculty of Pharmacy, Wakayama Medical University)
[29PA-308S]Preparation of tea leaf-derived particles having near-infrared light responsiveness and anti-tumor effects
○Keito Suzuki1, Risa Kanai1, Ryuichiro Suzuki1, Masashi Kitamura1, Syuuhei Komatsu1, Hiroaki Todo1 (1. Fac. Pharm. Pharm. Sci., Josai Univ.)
[29PB-309]Preparation of a Stable Indomethacin Supersaturated Solution Using Hydrophobically Modified Hydroxypropylmethylcellulose and α-Cyclodextrin
Hiroki Akahoshi3, Fumitoshi Hirayama2, Kenjirou Higashi4, ○Daisuke Iohara1,2,3 (1. Fac. Pharm. Sci., Sojo Univ. , 2. DDS Res. Insti. Sojo Univ., 3. Grad. Sch. Pharm. Sojo Univ., 4. Grad. Sch. Pharm. Chiba Univ.)
[29PA-310]Preparation of ionic liquids-mediated micelles for intranasal administration and encapsulation of NSAIDs
○Naoto Suzuki1, Mihoro Kobayashi1, Hinano Yamamoto1, Masahito Tsukamoto1, Manato Yamamoto1, Taiki Nagatomo1, Toyofumi Suzuki1 (1. School of Pharmacy, Nihon University)
[29PB-311S]Design of intranasal powder formulation of ionic liquids encapsulated in mesoporous silica
○Chihiro Shoda1, Naoto Suzuki1, Ayu Tochigi1, Nichika Yahagi1, Taiki Nagatomo1, Toyofumi Suzuki1 (1. School of Pharmacy, Nihon University)
[29PA-312S]Dry coating of mini-tablets using a conical ribbon mixer
○Haruka Mogami1, Haruka Manose2, Takayuki Arai2, Tatsuhiko Nakamura3, Minami Kishimoto4, Ryota Tanemura4, Hirohito Terada4, Mayumi Ikeda1, Tatsuya Fukuta1, Kazunori Kadota1 (1. Wakayama Med. Univ., 2. Okawara MFG.Co.,Ltd., 3. Higuchi Inc., 4. Ohara Pharmaceutical Co., Ltd.)
[29PA-313]Development of Wound Healing Formulations by Drug Repositioning
-Preparation and Evaluation of Novel Wound Healing Formulations Containing Irsogladine Maleate-.
Saki Yamaguchi1, Ryoko Takasawa1, Kaoru Hirose1, Yuko Imanaka2, Kaoru Oda4, Kazuhide Ashizawa3, Fumiyoshi Ishii2, ○Takehisa Hanawa1 (1. Tokyo University of Science, 2. Meiji Pharmaceutical University, 3. SSCI Institute, 4. Summit Pharmaceuticals International)
[29PA-314S]Investigation of preparation of nanocrystals containing lamotrigine using microfluidic devices
○Akihiro Makino1, Taiki Nagatomo1, Naoto Suzuki1, Toyofumi Suzuki1 (1. School of Pharmacy, Nihon University)
[29PB-315S]Development of a thermoresponsive polymer formulation encapsulating GGsTop for the treatment of anticancer drug-induced stomatitis
○Ritsuki Okada1, Issei Takeuchi2, Shoko Itakura1, Kosuke Kusamori1, Makiya Nishikawa1, Akiyoshi Saitoh1 (1. Fac Pham Sci, Tokyo Univ Sci, 2. Fac Pham Sci, Josai Int Univ)
[29PA-316S]Effect of AOT organogel formed by β-Arbutin on Skin Permeation
○JEONGEUN LEE1, Yoshihiro Tokudome1,2,3 (1. Grad. sch. AH. Sci., Saga Univ., 2. Grad. sch. SE. Sci., Saga Univ., 3. IOES., Saga Univ.)
[29PB-317S]Characterizations, in vitro skin penetration, antioxidant activity: piceatannol nanoparticles using physical and chemical technology
○Yi-Jia Yang1,3, Tzu-Hui Wu2, Feng-Lin Yen1, Hsuan Fu4 (1. Master Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80756, Taiwan., 2. Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, Pingtung 90741, Taiwan., 3. Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80756, Taiwan., 4. Doctoral Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.)
[29PA-318S]Investigation of nanostructure of the stratum corneum for development of transdermal formulation
○SHU MAO1, ishida kenya2, Yuri Ikeuchi1, Yasuko Obata1 (1. Hoshi University, 2. Takasago International Corporation)
[29PB-319]Powdering of Ink-Type Surface-Enhanced Raman Scattering (SERS) Tags and Their Application to the Direct Compression Process for Anticounterfeiting
○Toshiya Yasunaga1,2, Takao Fukuoka2, Akinobu Yamaguchi2,3, Hiromitsu Yamamoto1 (1. Laboratory of Pharmaceutical Engineering, School of Pharmacy, Aichi Gakuin University, 2. Archilys Corporation, 3. Department of Electrical, Electronic and Communications Engineering, Faculty of Science and Engineering, Toyo University)